This roundup is supposed to focus on a number of the most notable funding rounds of the month and isn’t meant to be complete.
Well being tech firms made a number of main funding bulletins in December. Here’s a checklist of a number of the greatest funding rounds.
ŌURA raises $200 million in Sequence D funding
ŌURA, which was based in Finland in 2013, supplies a sensible ring known as the Oura Ring and an accompanying app. The ring affords personalised insights and steerage on sleep, exercise, readiness, stress, resilience, ladies’s well being and coronary heart well being.
Constancy Administration & Analysis Firm and Dexcom participated in ŌURA’s $200 million Sequence D spherical. ŌURA has raised greater than $550 million up to now, and its Sequence D spherical brings its valuation to $5.2 billion. The funding will assist the corporate in increasing its product choices and exploring potential acquisitions.
Cleerly secures $106 million in Sequence C funding
Denver-based Cleerly makes use of FDA-cleared synthetic intelligence-powered options to allow detailed phenotyping of coronary artery illness, based mostly on superior non-invasive CT imaging.
Its $106 million funding elevate was led by Perception Companions and joined by Battery Ventures with participation from pre-existing traders. The funding will assist Cleerly “proceed to scale its industrial development and scientific proof technology, serving to well being care professionals enhance outcomes for sufferers throughout the coronary care pathway,” the announcement mentioned.
Rework Well being snags greater than $100 million
Indianapolis, Indiana-based Rework Well being helps employers and workers construct and entry Particular person Protection Well being Reimbursement Association (ICHRA) plans. ICHRA permits employers to supply workers a month-to-month allowance of tax-free cash that they’ll use to purchase healthcare companies for his or her wants. Rework Well being’s companies embrace plan creation and administration, name heart assist, automated quoting and worker onboarding.
The $100 million in financing is from Oak HC/FT and Hercules Capital. The funding will assist the corporate develop nationally, advance its platform capabilities and develop its partnerships with brokers, companies and carriers.
Cala Well being raises $50 million
San Mateo, California-based Cala Well being is a bioelectronic drugs firm. It affords FDA-cleared, noninvasive gadgets for hand tremors.
The $50 million elevate was co-led by Vertex Progress Fund and Nexus NeuroTech Ventures and included participation from Motion Potential, Johnson & Johnson, Lightstone, Lux Capital, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
Soda Well being secures $50 million in Sequence B funding
Bentonville, Arkansas-based Soda Well being connects well being plans and their members with a community of shops to assist advantages for meals, well being merchandise and pharmacy companies. It supplies a sensible advantages card that members can use on permitted items and companies. As well as, prospects obtain an evaluation to assist them discover care gaps and enhance star scores. Soda Well being additionally affords instruments to assist well being plans simulate totally different combos of well being advantages.
The $50 million Sequence B financing spherical was led by Basic Catalyst and included participation from former Humana CEO Bruce Broussard, Lightspeed Enterprise Companions, Outline Ventures, Qiming Enterprise Companions USA and SVB Capital. Soda Well being has raised $100 million in complete. The corporate will use the financing to scale its operations, launch new knowledge merchandise and develop to new profit classes.
Image: Feodora Chiosea, Getty Photographs
